SCHEMBL30987151

SCHEMBL30987151

C=CCN(C[C@H](O)COCc1ccccc1)C(=O)OC(C)(C)C

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.51
L3MBTL1 Q9Y468 4/20 0.46
CA1 P00915 3/20 0.44
PPARA Q07869 2/20 0.43
CA2 P00918 1/20 0.42
CA7 P43166 1/20 0.42
CA9 Q16790 1/20 0.42
CTSS P25774 1/20 0.41
HDAC3 O15379 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC2 Q92769 1/20 0.41
NCOR2 Q9Y618 1/20 0.41
BACE1 P56817 3/20 0.40
CASR P41180 1/20 0.40
PPARG P37231 1/20 0.40
MAPK1 P28482 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22785775 0.87 HDAC3 (0.53) NPSR1L3MBTL1CA1PPARACA2
SCHEMBL30987118 0.85 NPSR1 (0.48) NPSR1L3MBTL1PPARACTSSHDAC3
SCHEMBL16633128 0.85 CA1 (0.47) NPSR1L3MBTL1CA1PPARACA2
SCHEMBL16633129 0.85 CA1 (0.47) NPSR1L3MBTL1CA1PPARACA2
SCHEMBL30819017 0.83 L3MBTL1 (0.47) NPSR1L3MBTL1CA1PPARACA2
SCHEMBL30819037 0.83 L3MBTL1 (0.47) NPSR1L3MBTL1CA1PPARACA2
SCHEMBL31127362 0.83 NPSR1 (0.47) NPSR1L3MBTL1CA1PPARACA2
SCHEMBL30819090 0.83 NPSR1 (0.47) NPSR1L3MBTL1CA1PPARACA2
SCHEMBL24323788 0.81 CA1 (0.50) NPSR1L3MBTL1CA1PPARACA2
SCHEMBL7053417 0.81 CA1 (0.50) NPSR1L3MBTL1CA1PPARACA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4646265-A1 NOVEL, REVERSIBLE DPP1 INHIBITORS AND USES THEREOF Insmed Incorporated (US) 2025-11-12 EP disclosed
WO-2024148308-A1 NOVEL, REVERSIBLE DPP1 INHIBITORS AND USES THEREOF INSMED INCORPORATED (US) 2024-07-11 WO disclosed